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1. Introduction
In 2012, the American Diabetes Association stated that 
one-tenth of all health care dollars were spent on costs 
directly attributable to diabetes—the total cost: $245 
billion. More importantly, over half of this cost was directly 
or indirectly resulting from poor maintenance of blood 
glucose (BG) levels [3]. Diabetes has two classifications 
with accompanying medical conditions—depending upon 
the glucose level. Type 1 diabetes (T1D) is characterized 
by deficient insulin production and requires external insulin 
administration every day, and Type 2 diabetes (T2D) is an 
outcome of the body’s ineffective usage of insulin [6]. The 
direct healthcare costs per-person for Type 1 diabetes 
(T1D) are 50% higher than for Type 2 diabetes (T2D) [1]. 
According to recent data, there are more than 970K people 
living in the US who have T1D, with projections that by 
2050, more than half of these will be children. Diabetes 
mellitus is a chronic disease caused by the body’s 
insufficient production of insulin. As a hormone, insulin 
regulates BG levels, thus diabetics take insulin as an 
external medication to regulate BG levels [2]. 
      Managing diabetes requires tight control of BG levels, 
where too high BG results in hyperglycemia (HYPER) and 
causes long-term complications. Conversely, low BG 
results in hypoglycemia (HYPO, i.e., BG levels of <70 
mg/dL) [4] and can cause short-term complications 
including unconsciousness or permanent brain damage. 
Severe complications can lead to  death. HYPO, common 
in T1D, is most dangerous for infants, young children [16], 
elderly [10]. Individuals with diabetes have differing ability 
to sense their HYPO symptoms, and some can entirely lose 
the ability over time, a condition called hypoglycaemia 
unawareness [8]. In addition, the fear of the impaired 
cognition and more dramatic symptoms of HYPO causes 
many patients to err towards HYPER and lead passive life-
styles, including decisions not to engage in healthy exercise 
[5] and not driving [14].
Of the mHealth diabetes devices and applications (apps)
on the market, there are four basic ways of glucose 
monitoring: skin prick, saliva, urine, and continuous 
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glucose monitoring (CGM) systems. The most used 
methods for detecting HYPO are invasive and rely on 
analyzing glucose levels in blood (through a lancet finger-
stick) or interstitial fluids (through a subcutaneous injection 
of a CGM) [9]. However, CGMs often under-report HYPO 
[7] or display a significant time lag before indicating
HYPO [11]. For an individual with hypoglycaemia
unawareness, this can lead to a dangerously low BG before
it is treated. A recent study showed CGMs may not
significantly improve glycemic control in children with
T1D  [12]. Each method has its own limitations related to 
invasiveness, expense, and availability. There is, however,
a method that has shown considerable promise is trained
canines—diabetes alert dogs (DADs), that act as an early 
warning system by alerting patients without any noticeable
symptoms of HYPO [15] [16].
      As noted, research has demonstrated that DADs can 
smell the metabolic by-products of HYPO even before it 
registers on a glucose-based detection device, prompting 
patients to check their BG levels and take action before 
they suffer a HYPO episode. This early detection is due to 
the ability of DADs to smell volatile organic compounds 
(VOCs) from breath caused by metabolic changes that lead 
to HYPO, not by smelling glucose itself. Preliminary 
studies indicate patients with DADs have improved 
glycemic control and improved quality of life with fewer 
complications and lower healthcare costs. However, there 
are long wait-lists and many costs associated with training 
and maintaining DADs. As such, we believe an accurate, 
affordable, and non-invasive device can be designed to 
detect (through human breath) these metabolic changes. 
The smart sensor system will mimic the DAD’s ability to 
detect HYPO from VOCs in breath—thus being a 
technological breakthrough in hypoglycemic detection, 
while decreasing costs of care, decreasing morbidity and 
mortality, and transforming the health and well-being of 
patients with diabetes. 
2. Proposed Research
In response to these challenges, we are in the final phase of 
designing and developing a non-invasive connected mobile 
health system for T1D and T2D patients—that includes a 
canine-inspired, smart nanosensor (breathing device) 
technology that connects via Bluetooth with a mobile app. 
We tentatively refer to the system as: HYPOalert. The app 
has the capability of 24/7 (HIPAA compliant) 
determination of HYPO, while providing early warning 
alerts detecting chemical changes in human breath. 
Incorporated into a smart device, the sensor system will 
communicate health data to caregivers, collect data for 
proactive HYPO treatment, and integrate with other 
diabetes management devices. See Figure 1. 
Thus far, the research team has collected and analysed 
human breath samples using gas chromatography/mass 
spectrometry—creating signature VOC breath profiles that 
correlate to HYPO. Second, the design, fabrication and 
testing of the nanosensor array and breathing smart sensor 
device will allow patients to obtain a registered response—
arising from any detected metabolic change during a 
transient condition leading to HYPO. Each sensor on the 
array will respond to one or more of the identified VOCs. 
The sensor array will be equipped with computational 
resources and wireless data transmission-communication 
modules. Data will be transmitted via Bluetooth and mobile 
devices (e.g., smartphone)—alerting patients or caregivers 
(between doctor-recommended blood glucose measurement 
intervals) that the patient may be trending towards HYPO 
and needs to test BG levels or take immediate corrective 
action.  
The focus of this paper (and subsequent presentation) 
will review the design and testing of the first two 
prototype iterations of the mobile app—that will 
accompany the forthcoming smart breath device system. 
Figure 1. Illustrates the nanosensor array and device 
configuration with breath-inlet, antenna, battery, Bluetooth, 
and charger.  
3. Design Iteration—Phase 1
3.1. Design Process 
Based on a preliminary review of existing diabetes 
products and mobile apps, we developed a series of 
exploratory static/rapid interfaces for inspection by 
diabetes patients. As outlined, the primary purpose of 
HYPOalert is to warn patients of an approaching or 
existing state of HYPO. For this reason, the initial 
interfaces reflect this primary functional aspect. Figure 2 
illustrates the first conceptual iteration of HYPOalert. 
Based on this iteration of interfaces, we performed a user 
requirements study—focusing on understanding user 
needs through questionnaire, semi-structured interviews, 
and a preliminary review of the first iteration of the 
mobile app interface design. Findings provided design 
requirements and the users’ overall perception and interest 
in a breath smart sensor app for supporting HYPO 
monitoring. 
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Figure 2. First iteration of the HYPOalert static interfaces. 
First interface displays the app splash-page, with 
remaining interfaces indicating the patient’s name and 
reading date/time. Interfaces 2—3: (1) Three color-coded 
visualization areas: Green=NORMAL, 
Yellow=APPROACHING (or Caution), and Red=HYPO, (2) 
Hourly indication of breathing times and their location on 
the HYPO visualization scale, and (3) breathing times over 
several months. On the bottom: Interface (L) display 
breakdown fo the patient’s weekly breathing summary in 
percentages; and last interface (R) demonstrates 
HYPOalert on smartphone in hand. 
3.2. Methods 
Participants: We recruited 20 participants with Type 1 
and Type 2 diabetes (12 T1D / 60%; 8 T2D / 40%), 
n=20. Recruitment included paper flyers that were 
circulated throughout the University of Illinois at 
Chicago (UIC) campus and a bulk email sent through the 
UIC listserv system to all UIC staff and students. All 
participants received an Amazon $10 eGift for their 
participation, sent via email. Inclusion criteria included: 
volunteer’s age must be above 18 years, must speak 
fluent English, and must have Type 1 or 2 diabetes. All 
vulnerable populations were omitted. 
     Interview, Questionnaire and Rapid Prototype 
Review: All participants received eight open-ended 
interview questions and 13 multiple-choice survey 
questions. At the conclusion of the questionnaire, 
participants were shown the first iteration prototype of 
the mobile app interface design of HYPOalert. After a 
short time to review the interfaces, all participants were 
given follow-up questions related to the product’s 
benefits, functionality, and overall appeal.  
     Data Analysis: The results from 13 survey questions 
were analysed by calculating the mean and standard 
deviations (SD)—converting integer values using Excel 
2010. Using histogram values, each question was 
displayed as bar plots and pie charts graphics.  
3.3. Findings 
Questionnaire: Questionnaire results regarding the 
method for tracking BG levels showed that 65% 
participants use the skin prick, 30% used both continuous 
glucose monitoring and skin prick, and 5% used urine 
testing. Regarding HYPO management, 35% of 
participants had sugar intake at random hours, 25% make 
use of health apps to track glucose levels by measuring 
food intake and physical exercise, while only one 
participant uses noninvasive glucose tracking. Only three 
participants use a combination of all three methods for 
managing hypoglycemic levels. Only 20% of participants 
did not use any method to track their hypoglycemic 
levels.  
With regard to levels of satisfaction with current 
monitoring systems, 10% of participants were pleased 
with their current system, 45% participants were 
somewhat satisfied, and 40% were not satisfied with 
their current BG measuring method or devices. A total 
of 85% of participants expressed their interest to use the 
proposed HYPOalert breathing sensor over their current 
HYPO management device. Regarding the extent of use 
of a breathing sensor, 70% wished to use HYPOalert 
more than 20 times a day, if available—while only 20% 
expressed that they would only use it once a day to 
manage their HYPO condition. 
Regarding preferred BG data display types, 40% of 
participants wanted to see their data visualized along 
with alerts, rather than a color-coded visualization. At 
the same time, 45% wanted to see the data visualization 
color-coded, with numbers, color coding data, and 
line/bar plots—similar to the HYPOalert app interface. 
Finally, 15% expressed an interest in only visualizing 
their BG data with bar or line plots. And, regarding 
sharing their data with others, 95% stated their interest 
in including their family, while 90% wanted to include a 
means to share their HYPO data with their primary 
provider.  
All participants were interested in using the 
HYPOalert app, with its data visualization system—
stating that it would help advance their understanding 
and management of their HYPO condition. All 
participants (100%) were slightly to strongly in 
agreement that the proposed HYPOalert system (sensor 
and app) would positively impact their daily lifestyle 
practices. 
Open-Ended Interview: The results of the interviews 
demonstrated that the frequency of both severe HYPO 
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and mild HYPO episodes among the participants. We 
found that the occurrence of mild HYPO episodes 
(5.1±7.3 times per week) was approximately 10-fold 
higher than the severe HYPO episodes (2.1±2.3 times 
per month). The average participants monitoring of 
Blood Glucose (BG) levels was 2.8±2.9 times per day—
while BG monitoring still varied from patient to patient. 
For example, one T1D participant monitors BG levels 10 
times a day, whereas four participants check their BG 
randomly throughout the week.   
Approximately 80% of participants use BG 
measuring devices to specifically manage their 
hypoglycemia. Although most participants use 
traditional or advanced BG monitoring devices, the 
adoption of mHealth apps is very poor, i.e., 75% of 
participants do not use any type of mobile app that links 
their BG results from the device to their smartphone. 
The remaining 25% use GoMeal, Dexom, OneDrop, or 
other apps to review BG data from their monitoring 
devices.  
Regarding the use of HYPO data visualization, the 
majority of participants (70%) recommended that the 
device saves the breathing sensor data through a log 
option (up to six months), with the ability to visualize 
the data at any point in time according to glucose levels, 
mg/dL, and trends. In addition, three participants 
expressed their interest to include an option for food 
intake data; whereas one participant suggested we 
include an insulin dosage option that alerts when HYPO 
occurs. Two patients would like to include predictions or 
causes of HYPO. 
4. Design Iteration—Phase 2
4.1. Product Review 
To obtain a more precise understand of the advancements 
of other mHealth diabetes products, we conducted an 
system and interface design audit of two FDA approved 
mobile products that include both a BG measuring device, 
with data transmission capabilities (via Bluetooth or 
directly) to a smartphone app. Our assessment included 
the Dario and iHealth wireless blood glucose monitoring 
systems. After registering online, our team tested and 
assessed the products for two weeks; including daily 
blood samples. We then de-constructed and built an 
interface/system information architecture flow-chart, 
followed by a comparative analysis of the two products 
using the same criteria. 
In sum, both apps offer innovative solutions that 
improve patient satisfaction by enabling them to manage 
health more efficiently. Patients can set thresholds for 
normal and danger glucose levels, personalized goals, 
medication reminders, diet, and exercise plans. Both 
products allow users to log their blood sugar level 
manually, using the device as often as they want. They 
can also follow their progress visually, and export results 
as an Excel, PDF, or CSV file to their healthcare provider 
or family members using e-mail, text, or via shared access 
in social media. 
Our findings showed also showed that there was a lack 
of consistency in color codes when displaying some of the 
HYPO BG reading levels, creating some confusion in 
interpreting the results. For example, although iHealth had 
a well-designed interface and visualization system, the 
color coding system was difficult to distinguish. While 
Dario provided access to most options with an inside 
menu, iHealth features and commands can be accessed 
directly from the interface icons, text, or a combination of 
both. Unlike Dario, iHealth requires Bluetooth 
connection, and does not support the visually impaired. 
However, Dario supports adding emergency contacts and 
uses GPS to locate the patient when BG levels reach a 
dangerous range. 
4.2. Design Process 
Findings from the first iteration and the review of the two 
BG monitoring systems informed our design of the phase 
two interactive prototype (Figure 3).   
4.3. Methods 
Participants: Inclusion criteria for study two included: 
participants had to be a graduate student or staff of the 
University of Illinois at Chicago (UIC), must be 18 years 
or older, and must speak fluent English. Recruitment was 
done by circulating invitations for the study across the 
college via emails, and all vulnerable populations were 
omitted. The final sample included 14 volunteers from 
UIC students (78%) and staff (22%). The majority of 
participants were females (71%), and participants age 
ranged from 18 to more than 50 years old (average age 34 
years). All participants received an Amazon $10 eGift for 
their participation.  
     Usability Testing: A three-part usability test was done 
on the interactive prototype (on an iPhone 7 Plus). First, a 
scenario task-based time-on-task study was completed, 
that included five tasks related to: 1) registration, 2) 
setting goal, 3) logging measurements, 4) viewing results 
and trends, and 5) sharing the results of that day’s 
readings with another person. All participants were 
observed, and voice recordings were conducting for all 
task exercises. Second, a post-test questionnaire that 
included 35 questions was completed by the participants. 
Twenty-nine questions were grouped in seven categories 
pertaining to design, functionality, navigation, 
architecture, benefits, overall appeal of the prototype, and 
demographics. The participants answered the questions, 
using a 6-point Likert scale, with 1, signifying strongly 
disagree to 6, signifying strongly agree. In addition, there 
were five questions related to the participants’ 
demographics and experience with mobile phones. Also, 
there was one question related to the overall total score 
for user’s satisfaction and experience with the HYPOalert 




mobile app—using a 10 point scale. Finally, we asked 
seven open-ended post-test interview questions related to 
the participants’ experience using the HYPOalert 
prototype. The intent was to obtain an in-depth 
understanding of individual experience, perception, and 
motivating factors for using HYPOalert, followed by any 
final recommendations. 
     Data Analysis: The amount of time participants spent 
to complete each task was measured using descriptive 
analysis to calculate min, max and average time spent on 
each task, as well as the whole test. Users’ responses 
during the think aloud process were captured and a 
thematic content analysis was employed to analyze the 
data. The responses were organized according to the 
theme of issues raised during the test to calculate 
percentage of users who reported the same issues. Survey 
results for the 35 questions were analyzed by calculating 
frequency (within the six-point Likert scale—from 
strongly disagree to strongly agree, with conversion 
percentages using Excel 2010. We first averaged the 
scores of each question, according to the responses from 
the 14 participants. This was followed by averaging those 
frequency scores that pertained specifically to each focus 
area of the questions shown in Table 1.  
Table 1. Survey focus areas and number of 
questions. FOCUS AREA OF QUESTIONS # OF QUES. 
User Interface 6 
Design Consistency and Flexibility 6 
Navigation and Information Architecture 9 
App Learnability 8 
Overall Score 1 
Usage and Demographics 5 
As such, we could determine to what degree or percentage 
the overall response was within the range of responses 
from strongly disagree to strongly agree. For example, 
under group one, “User Interface Design,” there were 6 
questions that provided frequencies, with a total overall 
score of 62%. This frequency score conveyed the degree 
to which the participants agreed or strongly agreed (liked) 
the prototype user interface design.   
      For the interview results, thematic content analysis of 
the narrative responses was used. The text narrative 
responses were organized according to concepts and 
summarized into categorical statements in a spreadsheet 
to identify key concepts. Confidentiality of the 
participants was maintained by deidentifying the data and 
aggregating it into an Excel file for data analysis.  
4.4. Findings 
Usability Testing: Analysis of the results from observing 
the participants and thematic analysis of their responses 
during task implementation, demonstrated that the most 
prevalent usability issues reported by 93% of users were 
manual entry of BG into HYPOalert system and 
interpreting the data visualizations on the logbook. Most 
users preferred to have the layout of logbook 
customizable, with clearer actions for selecting the 
commands on the screen. The second issue reported by 
86% of participants were challenges using the menu 
options to navigate between different sections of the 
system. Most users preferred commands as buttons 
displayed on the interface, rather than hidden inside the 
menus. More than 50% of participants commented on 
clarity of the visuals and display of the legend, colors 
used, and use of pie charts for displaying the percentages 
of monthly low, normal and high readings. The average 
time to complete all 5 tasks and their corresponding 
subtasks was 11.2 minutes (MIN: 6.5 mins, MAX: 26 
mins). 
Figure 3. Illustrates the second iteration 
HYPOalert interactive prototype that focus on data 
monitoring using several temporal systems, the 
alert system, along with reminders, settings, 
and summary reports. 
     Questionnaire: Regarding the user interface design, 
92% of participants agreed or strongly agreed with the 
overall design, 100% considered the color palette for the 
interfaces, and other visuals and text was appealing, but 
only 64% considered the menus as distinct from other 
displayed information. Regarding design consistency and 
flexibility, about 70% of participants agreed that the 
design was consistent and flexible. Among those, 86% 
agreed that the display formats was consistent, but 64% 
concurred that the app needed to provide more user 
guidance.   
     Navigation and information architecture got the lowest 
rank of 65% agreement among all tested areas. This result 
was consistent with other themes that emerged from the 
study, i.e., participants expressed concerns with 
navigation. Based on the survey results, the participants 
primary navigation issues were difficulties in finding their 
current position in the menu structure (50%) and the 
Home page location (43%). About 71% of participants 
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agreed that the app was easy to learn, and 90% of those 
agreed the use of words or labels  were easy to learn. 
However, 50% of participants considered there are not 
enough Cancel options in the app to help them correct 
their erroneous or missteps as they navigated through the 
system. Finally, regarding the overall satisfaction and user 
experience with the mobile app, the score was 6.64 out of 
10. 
Open-Ended Interview: Several themes emerged 
from the outcomes of our interview questions. First. 
100% of participants considered the HYPOalert system 
has a great value and would positively impact diabetics 
patients with their daily lifestyle practices, self-
managing of their disease, and would help advance their 
understanding and management of a HYPO condition.  
A majority of the participants (92%) considered the data 
visualization and color-coded charts with numbers as the 
best feature, and the one they enjoyed the most in the 
HYPOalert system. A positive first impression of the 
system was reported by 85% of the users. The common 
themes (85%) emerging from the responses regarding 
the participants’ negative experience with the menu 
options and buttons, i.e., confusion caused difficulties to 
navigate among different parts of the system. Based on 
the final interview responses related to frustrating 
features of the system, 43% reported navigation, and 
14% reported logbook visuals and BG manual entry 
processes. 
5. Conclusion
Hypoglycemia can be a life-threating condition, of 
which regular metabolic monitoring is critical. There is 
need for technologies that can help diabetes patients detect 
and treat HYPO episodes. This is especially true for 
diabetes patients that suffer from general hypoglycemia or 
hypoglycemia unawareness, i.e., a rapid drop in BG 
without any physiological symptoms. Many traditional 
methods such as urine tests focus on detecting elevated 
blood glucose methods, and more modern CGM devices 
can delay the reporting of HYPO episodes until a patient is 
too compromised for self-treatment. This paper reported on 
a two design iterations of a dedicated HYPO monitoring 
mobile app (HYPOalert), that will accompany a new 
noninvasive smart sensor that detects HYPO by human 
breath for Type 1 and 2 diabetics.  
After our first design iteration, we interviewed users 
regarding the system (with static prototypes). Findings 
suggest a strong reception of HYPOalert. Participants 
agreed that the proposed system will have a positive 
impact on managing their HYPO. We then conducted the 
evaluation of two FDA approved mHealth BG monitoring 
systems to compare and assess product features. Our 
comparative analysis was used to inform and enhance the 
prototype design of the second iteration. We confirmed 
that customizing BG thresholds for normal. Customization 
also included setting dangerous levels to enable HYPO 
alerts and allowing patients to define their own BG self-
management plan.  Finally, a usability study was used to 
test the second iteration of the HYPOalert prototype, ease 
of use and functionality.  
The results showed 100% of participants found the 
HYPOalert mobile app could have a positive impact on 
diabetic patients’ lifestyle, self-managing of the disease, 
and daily managing the overall HYPO condition. Study 
findings also showed 100% of participants considered the 
visualization of data and text in the HYPOalert app 
appealing, and 92% agreed with the overall interface 
design. Usability testing results provided significant lessons 
learned for how to improve the navigation, data 
visualizations, history logs of BG level readings/trends, 
customizable timeframes, and a legend color coding system 
that accompanies the BG values displayed. The insights 
captured from the usability study will guide the third design 
iteration of the actual product, followed by randomized 
control trial with patients.  
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